Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

Perspectives in Major Depressive Disorder

neuroscienceCME Multimedia Snack

Premiere Date: Wednesday, November 5, 2014

This activity offers CE credit for:

1. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Thursday, November 5, 2015
Note: Credit Is No Longer Available

Faculty

David C. Steffens, MD, MHS  Professor and Chair Department of Psychiatry University of Connecticut Health Center Farmington, CT

Charles B. Nemeroff, MD, PhD  Professor and Chair Department of Psychiatry Mulva Clinic for the Neurosciences Director, Institute of Early Life Adversity Research Dell Medical School The University of Texas at Austin Austin, TX

Statement of Need

Major depressive disorder (MDD) is now the second leading cause of disability worldwide and a major contributor to the health care burden, new data indicate.¹ Establishing an effective treatment remains an outstanding need: up to 70% of patients with MDD do not reach remission with an adequate course of an antidepressant, and they also experience poorer long-term outcomes.²

This neuroscienceCME Snack on MDD offers new perspectives on treating this pervasive disorder and highlights residual symptoms as a challenge to clinicians.

---

1. Ferrari AJ, Charlson FJ, Norman RE, et al. The epidemiological modelling of major depressive disorder: application for the Global Burden of Disease Study 2010. PLoS One. 2013;8(7):e69637. PMID: 23922765.
2. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. PMID: 16390886.

Activity Goal

This educational activity centers on the CME Outfitters Make One Change statement. This statement is crafted from pertinent quality measures or clinical guidelines as a performance challenge to all participants. The Make One Change statement for this activity is:

Regularly use validated rating scales to monitor patients with a diagnosis of major depression.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Implement regular use of validated rating scales and questionnaires to establish a baseline assessment to objectively measure the changes in clinical status over time of patients being treated for major depressive disorder to remission.
• Proactively engage the patient in the development of a treatment strategy that includes discussion of cognition, remission, and treatment side effects, and document the plan for the patient.
• Evaluate available efficacy evidence regarding the current and latest approved therapeutics for the treatment of MDD.

Financial Support

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., U.S. Region and Lundbeck.

Target Audience

Physicians and other healthcare professionals who treat individuals with major depressive disorder.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST927 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

All faculty participating in CME Outfitters continuing education activities are required to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME's Standards for Commercial Support, and other accrediting and regulatory bodies. Full disclosure of faculty relationships will be made on this website and within the activity course materials prior to the premiere date of this activity.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).